Literature DB >> 2474815

Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary.

L Stefaneanu1, E Horvath, K Kovacs.   

Abstract

Nucleolar organizer regions (NORs), claimed to represent valuable markers of tumor proliferation, were visualized on paraffin sections by an argyrophil method and counted in 18 nontumorous adenohypophyses and 132 pituitary tumors. The AgNOR counts could not be correlated with the hormonal activity of nontumorous and adenoma cells. In pituitary adenomas, the mean AgNOR values were higher than in their corresponding nontumorous cell types. Some adenomas, especially growth hormone (GH), and prolactin (PRL) cell adenomas, however, had AgNOR readings in the range of nontumorous cells. Long-acting somatostatin analog and bromocriptine treatment decreased AgNOR counts in GR- and PRL-producing tumors. Most, but not all invasive and/or recurrent adenomas had high AgNOR counts. In a corticotroph carcinoma, AgNORs were not higher than in the adenomas. These inconsistent results limit, at the present time, the use of AgNORs as reliable markers of cell proliferation in pituitary tumors. Further studies may help to establish the value of this promising method in pituitary pathology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474815

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

1.  Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.

Authors:  M Shibuya; F Saito; T Miwa; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Histopathological study comparing upstream binding factor expression and AgNOR staining.

Authors:  A Torres-Montaner; M Huq
Journal:  Cell Prolif       Date:  2012-08       Impact factor: 6.831

Review 3.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Correlation between PCNA expression and AgNOR dots in pituitary adenomas.

Authors:  M Klencki; I Kurnatowska; D Słowińska-Klencka; A Lewiński; M Pawlikowski
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Prognostic criteria in nonfunctioning pancreatic endocrine tumours.

Authors:  S La Rosa; F Sessa; C Capella; C Riva; B E Leone; C Klersy; G Rindi; E Solcia
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

6.  Silver-Staining Nucleolar Organizer Region Quantification in Pituitary Adenomas.

Authors:  Dorota Sowiska-Klencka; Mariusz Klencki; Marek Dedecjus; Andrzej Lewiski; Marek Pawlikowski
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.